This article is part of the supplement: Proceedings of Fibroproliferative disorders: from biochemical analysis to targeted therapies
Introduction
From biochemical analysis to targeted therapies
1 Hematology Oncology Center & Ludwig Maximilians University Medical School, Munich, Germany
2 University of California, San Diego, La Jolla, CA, USA
Fibrogenesis & Tissue Repair 2012, 5(Suppl 1):S1 doi:10.1186/1755-1536-5-S1-S1
Published: 6 June 2012First paragraph (this article has no abstract)
Abnormal fibrogenesis is a process which in practically every organ of our body can contribute to disease. In contrast to its paramount importance, too little is known about the pathophysiology of this process and therapeutical ways to interfere with this process.
